CareDx, Inc (CDNA) vs Pulse Biosciences, Inc. (PLSE)
A side-by-side comparison of CareDx, Inc and Pulse Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CDNA
CareDx, Inc
$64.63HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
PLSE
Pulse Biosciences, Inc.
$49.30HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
Total return — CDNA vs PLSE
growth of $100 · dividends reinvested · last 10yCDNA +1824.2% (+34.4%/yr)PLSE +700.3% (+23.1%/yr)CDNA compounded faster over this window
CDNA PLSE
CDNA vs PLSE: by the numbers
- •PLSE is the larger company ($3.41B vs $3.34B market cap).
- •CDNA is profitable (24.23% net margin) while PLSE runs a net loss (-6755.78%).
Metrics side by side
Valuation
| Metric | CDNA | PLSE |
|---|---|---|
| P/E ratio | 31.20 | N/A |
| Forward P/E | 53.95 | N/A |
| P/S ratio | 7.30 | 2879.36 |
| P/B ratio | 7.86 | 34.29 |
| EV / EBITDA | 192.12 | N/A |
| FCF yield | 2.54% | N/A |
Profitability
| Metric | CDNA | PLSE |
|---|---|---|
| Gross margin | 70.58% | -360.00% |
| Operating margin | -0.92% | -21982.57% |
| Net margin | 24.23% | -6755.78% |
| ROE | 26.08% | -80.46% |
| ROIC | -0.93% | -79.40% |
Growth (annualized)
| Metric | CDNA | PLSE |
|---|---|---|
| Revenue CAGR (5Y) | 12.56% | N/A |
| Total return CAGR (5Y) | 1.33% | 19.76% |
Frequently asked
- Is CDNA or PLSE more profitable?
- CDNA runs the higher net margin — CDNA at 24.23% versus PLSE at -6755.78%.
- How have CDNA and PLSE total returns compared?
- Over the past 10 years, CDNA delivered 34.41% and PLSE delivered 23.22% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
CareDx P/E ratioCareDx ROEPulse Biosciences ROECareDx operating marginPulse Biosciences operating marginCareDx revenue growthPulse Biosciences revenue growthCareDx free cash flowPulse Biosciences free cash flow
CareDx & Pulse Biosciences appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.